(in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
---|---|---|---|---|
Current assets | ||||
Cash | $2414.2 | $2722.29 | $2927.83 | |
Short term investments | ||||
Net receivables | $1177.32 | $1016.9 | $924.06 | $929.13 |
Inventory | $144.84 | $147.86 | $147.36 | $141.68 |
Total current assets | $4832.45 | $4409.14 | $4573.81 | $4910.59 |
Long term investments | $237.82 | $246.17 | $240.8 | |
Property, plant & equipment | $29608.68 | $29500.89 | $29531.04 | $29477.01 |
Goodwill & intangible assets | $6811.85 | $6839.07 | $6890.28 | |
Total noncurrent assets | $37406.32 | $37505.24 | $37457.96 | |
Total investments | $237.82 | $246.17 | $240.8 | |
Total assets | $42740.95 | $41815.46 | $42079.05 | $42368.55 |
Current liabilities | ||||
Accounts payable | $391.84 | $401.92 | $448.16 | $461.72 |
Deferred revenue | ||||
Short long term debt | $57.51 | $114.83 | $60.17 | |
Total current liabilities | $3886.76 | $3000.17 | $3033.99 | $3126.07 |
Long term debt | $6493.74 | $31403.6 | $31385.65 | $31471.27 |
Total noncurrent liabilities | $35001.14 | $35017.79 | $34908.33 | |
Total debt | $31461.1 | $31500.47 | $31531.45 | |
Total liabilities | $39509.01 | $38001.32 | $38051.78 | $38034.4 |
Shareholders' equity | ||||
Retained earnings | $3037.4 | $3172.24 | $3393.8 | $3664.01 |
Other shareholder equity | $191.57 | $37.38 | $59.81 | $143.9 |
Total shareholder equity | $3212.68 | $3456.76 | $3811.17 |
(in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Current assets | ||||
Cash | $2927.83 | $5911.89 | $5203.06 | $5101.64 |
Short term investments | ||||
Net receivables | $929.13 | $925.16 | $583.91 | $316.5 |
Inventory | $141.68 | $126.06 | $96.37 | $88.32 |
Total current assets | $4910.59 | $8154.69 | $6416.18 | $5950.66 |
Long term investments | $240.8 | $173.04 | $967.04 | $1447.04 |
Property, plant & equipment | $29477.01 | $29754.86 | $25928.3 | $22918.78 |
Goodwill & intangible assets | $6890.28 | $6580.56 | $7097.38 | $5735.03 |
Total noncurrent assets | $37457.96 | $37537.51 | $34482.93 | $30544.28 |
Total investments | $240.8 | $173.04 | $967.04 | $1447.04 |
Total assets | $42368.55 | $45692.21 | $40899.12 | $36494.93 |
Current liabilities | ||||
Accounts payable | $461.72 | $369.82 | $286.2 | $172.67 |
Deferred revenue | ||||
Short long term debt | $60.17 | $1369.92 | $1172.62 | $138.83 |
Total current liabilities | $3126.07 | $4515.89 | $3442.26 | $1856.58 |
Long term debt | $31471.27 | $7432.82 | $23573.26 | $20766.8 |
Total noncurrent liabilities | $34908.33 | $35966.19 | $26480.09 | $23458.44 |
Total debt | $31531.45 | $33952.04 | $24745.88 | $20905.63 |
Total liabilities | $38034.4 | $40860.68 | $29922.35 | $25315.03 |
Shareholders' equity | ||||
Retained earnings | $3664.01 | $4794.24 | $4340.59 | $3091.01 |
Other shareholder equity | $143.9 | $33.5 | -$24.62 | -$30.68 |
Total shareholder equity | $3811.17 | $4831.53 | $6070.65 | $6504.73 |
(in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $4183.14 | $4327.38 | $4383.47 | $4375.56 |
Cost of revenue | $2323.18 | $2360.81 | $2375.38 | |
Gross Profit | $1867.98 | $2004.19 | $2022.66 | $2000.19 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $1335.05 | $1324.35 | $1374.34 | |
Total operating expenses | $1535.62 | $1544.35 | $1539.16 | $1587.42 |
Operating income | $459.84 | $483.5 | $412.77 | |
Income from continuing operations | ||||
EBIT | $288.26 | $371.19 | $360.82 | |
Income tax expense | $52.57 | -$11.55 | $43.67 | -$59.52 |
Interest expense | -$151.47 | $112.74 | $110.04 | $106.88 |
Net income | ||||
Net income | $184.36 | $187.07 | $217.48 | $313.46 |
Income (for common shares) | $187.07 | $217.48 | $313.46 |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $16164.25 | $13127.49 | $5162.08 | |
Cost of revenue | $8553.56 | $6652.98 | $3452.71 | |
Gross Profit | $7610.69 | $6474.5 | $1709.37 | |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $5213.06 | $4705.73 | $2582.48 | |
Total operating expenses | $5657.09 | $4874.92 | $2394.74 | |
Operating income | $1953.6 | $1599.59 | -$685.37 | |
Income from continuing operations | ||||
EBIT | $1760.31 | $2765.11 | -$547.92 | |
Income tax expense | $157.84 | $697.07 | -$191.57 | |
Interest expense | $460.29 | $594.95 | $676.38 | |
Net income | ||||
Net income | $1142.18 | $1473.09 | -$1032.72 | |
Income (for common shares) | $1142.18 | $1473.09 | -$1032.72 |
(in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
---|---|---|---|---|
Net income | $187.07 | $217.48 | $313.46 | |
Operating activities | ||||
Depreciation | $320.9 | $325.07 | $332.85 | |
Business acquisitions & disposals | -$31.17 | -$10.52 | -$16.59 | |
Stock-based compensation | $12.54 | $26.78 | $27.36 | |
Total cash flows from operations | $474.24 | $549.27 | $715.94 | |
Investing activities | ||||
Capital expenditures | -$237.11 | -$171.53 | -$329.46 | |
Investments | -$9.33 | $73.05 | $50.88 | |
Total cash flows from investing | -$879.24 | -$277 | -$108.41 | -$293.62 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | -$408.77 | -$506.57 | -$623.03 | |
Net borrowings | $18.74 | -$86.31 | -$167.2 | |
Total cash flows from financing | -$773.8 | -$494.48 | -$628.97 | -$827.53 |
Effect of exchange rate | -$14.74 | -$10.67 | -$17.6 | $16.91 |
Change in cash and equivalents | $23.17 | -$307.91 | -$205.71 | -$388.3 |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Net income | $1142.18 | $1473.09 | $1254.37 | -$1032.72 |
Operating activities | ||||
Depreciation | $1330.25 | $3919.65 | $1339.53 | $1393.95 |
Business acquisitions & disposals | -$283.1 | $2229.92 | $1871.94 | $2358.91 |
Stock-based compensation | $73.61 | $71.3 | $65.18 | $106.96 |
Total cash flows from operations | $2690.78 | $1756.46 | $1373.42 | -$1493.04 |
Investing activities | ||||
Capital expenditures | -$465.99 | $401.26 | -$384.1 | -$264.44 |
Investments | $26.57 | -$523.36 | ||
Total cash flows from investing | -$714.17 | $2118.18 | $1543.64 | $2159.3 |
Financing activities | ||||
Dividends paid | -$4.05 | -$4.79 | -$77.61 | |
Sale and purchase of stock | -$2291.92 | -$2775.22 | -$1753.51 | -$353.72 |
Net borrowings | -$2404.44 | $76.57 | -$1365.17 | $2350.37 |
Total cash flows from financing | -$5004.63 | -$3024.3 | -$2814.09 | $2103.43 |
Effect of exchange rate | -$19.4 | $8.93 | -$1.55 | $2.35 |
Change in cash and equivalents | -$3021.49 | $833.33 | $101.42 | $2772.03 |
Market cap | $11.37B |
---|---|
Enterprise value | N/A |
Shares outstanding | 296.89M |
Revenue | $17.27B |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | $902.37M |
Revenue Q/Q | 5.28% |
Revenue Y/Y | 12.28% |
P/E ratio | 12.60 |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | 0.66 |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | $3.04 |
---|---|
ROA | 2.14% |
ROE | N/A |
Debt/Equity | 9.98 |
---|---|
Net debt/EBITDA | N/A |
Current ratio | 1.24 |
Quick ratio | 1.21 |